iflix
AstraZeneca's Executive VP sees upside as China's Government speeds up new drug approval

AstraZeneca's Executive VP sees upside as China's Government speeds up new drug approval

  • TV-G
  • 2019
  • 3mins
AstraZeneca PLC is betting on sales of its new drug to outweigh that of off-patient ones in China over the next five years amid Chinese regulator's expedited approval of new therapies to meet unmet medical demands. Leon Wang it's executive vice president overseeing international markets spoke exclusively to Selina Wang on Bloomberg Daybreak: Asia.